Key Drivers
- Cash Cushion
- Loss Pressure
- Weak Conversion
AIAI Summary
OMDA is evolving from a pure growth story into a scale-and-leverage play, with accelerating membership, new PBM/Lilly distribution, and positive adjusted EBITDA guidance suggesting real margin upside, but the stock still hinges on proving that this growth can convert into durable cash flow and recurring profits rather than episodic momentum.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Cash Cushion
- •Loss Pressure
- •Weak Conversion
OMDA has a strong cash buffer and no debt, but persistent losses, negative free cash flow, and weak recent cash conversion show the business still lacks durable earnings power.
Price Behavior
Key Price Behavior Insights:
- •Trend Recovery
- •Range Resistance
- •Support Holding
OMDA has trended higher over the last month, rebounded sharply from mid-May weakness, and remains constructive above $14.7 with $16.4-$16.6 as near-term resistance.
Sharp drop from $16.40 to $14.69, then a quick rebound to new short-term highs
Sentiment & News
Key News Insights:
- •Revenue surge
- •Membership expansion
- •GLP-1 traction
Omada Health reported a strong Q1 with 42% revenue growth, 1.02M members, margin expansion and raised guidance, while expanding GLP-1 access through Lilly's Employer Connect and backing it with encouraging clinical results.
This update is positive for Omada Health, signaling accelerating scale, improving profitability, and stronger demand for its employer-focused care model
Similar Companies in Healthcare
Other companies in the same sector with AI ratings